Home » Topics » BioWorld Science

BioWorld Science
RSS

Animal model recapitulates CCA susceptibility in progressive biliary injury and fibrosis

Nov. 24, 2021

RaQualia Pharma synthesizes new TRPV4 antagonists

Nov. 24, 2021

Preclinical Alzheimer's vaccine, therapy target soluble amyloid

Nov. 24, 2021

Rhizen Pharmaceuticals synthesizes new PARP inhibitors

Nov. 24, 2021

A novel protein-engineered IL-12 shows efficacy without peripheral toxicity in animal models

Nov. 24, 2021

Perha Pharmaceuticals identifies CLK1 and/or CLK4 and/or DYRK1A inhibitors

Nov. 24, 2021

Novartis synthesizes HIF-2alpha inhibitors

Nov. 24, 2021

Idorsia Pharmaceuticals patents CCR6 antagonists

Nov. 24, 2021

ALTA-002, a Toll-like receptor agonist antibody conjugate with promising antitumor activity in vivo

Nov. 24, 2021

GNE-502 shows promising efficacy in breast tumor xenograft model

Nov. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...